Shopping Cart 0
Cart Subtotal
AED 0

Myriad Genetics Inc (MYGN) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258

Details

Summary

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company's product portfolio includes molecular diagnostic testing products that analyze genes, their expression levels and corresponding proteins to assess a person's risk for developing disease later in life; accurately diagnose disease; and determine a patient's likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Myriad Genetics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Myriad Genetics Inc Company Overview

Myriad Genetics Inc Company Snapshot

Myriad Genetics Inc Pipeline Products and Ongoing Clinical Trials Overview

Myriad Genetics Inc-Pipeline Analysis Overview

Business Description

Myriad Genetics Inc-Key Facts

Myriad Genetics Inc-Major Products and Services

Myriad Genetics Inc Pipeline Products by Development Stage

Myriad Genetics Inc Ongoing Clinical Trials by Trial Status

Myriad Genetics Inc Pipeline Products Overview

BRACAnalysis CDx-Metastatic Castrate-Resistant Prostate Cancer

BRACAnalysis CDx-Metastatic Castrate-Resistant Prostate Cancer Product Overview

ChemoPredict Test

ChemoPredict Test Product Overview

Diagnostic Assay-Lung Cancer

Diagnostic Assay-Lung Cancer Product Overview

Diagnostic Assay-HER2+/TNBC-Breast Cancer

Diagnostic Assay-HER2+/TNBC-Breast Cancer Product Overview

Diagnostic Assay-Juvenile Idiopathic Rheumatoid Arthritis

Diagnostic Assay-Juvenile Idiopathic Rheumatoid Arthritis Product Overview

Diagnostic Assay-Melanoma

Diagnostic Assay-Melanoma Product Overview

Diagnostic Assay-Prostate Cancer

Diagnostic Assay-Prostate Cancer Product Overview

Diagnostic Test-Alzheimer's Disease

Diagnostic Test-Alzheimer's Disease Product Overview

Diagnostic Test-Colon Cancer

Diagnostic Test-Colon Cancer Product Overview

Diagnostic Test-Kidney Damage

Diagnostic Test-Kidney Damage Product Overview

Genetic Risk Score Test

Genetic Risk Score Test Product Overview

Genetic Risk Score Test Clinical Trial

HRD Companion Diagnostic Test-Breast Cancer

HRD Companion Diagnostic Test-Breast Cancer Product Overview

Kidney Transplant Rejection Test

Kidney Transplant Rejection Test Product Overview

Multi-Biomarker Test-Ankylosing Spondylitis

Multi-Biomarker Test-Ankylosing Spondylitis Product Overview

Multi-Biomarker Test-Autoimmune Diseases

Multi-Biomarker Test-Autoimmune Diseases Product Overview

Multi-Biomarker Test-Inflammatory Diseases

Multi-Biomarker Test-Inflammatory Diseases Product Overview

Multi-Biomarker Test-Psoriatic Arthritis

Multi-Biomarker Test-Psoriatic Arthritis Product Overview

Multi-Biomarker Test-Systemic Lupus Erythematosus

Multi-Biomarker Test-Systemic Lupus Erythematosus Product Overview

myChoice Diabetes

myChoice Diabetes Product Overview

myChoice HRD (PARP)-Talazoparib

myChoice HRD (PARP)-Talazoparib Product Overview

myChoice HRD CDx Test-Zejula

myChoice HRD CDx Test-Zejula Product Overview

myChoice HRD CDx Test-Zejula Clinical Trial

myPath BiPolar

myPath BiPolar Product Overview

myPath Endometriosis

myPath Endometriosis Product Overview

myPath Pancreatic Cancer

myPath Pancreatic Cancer Product Overview

myPath Prostate Cancer

myPath Prostate Cancer Product Overview

myPath Psoriatic Arthritis

myPath Psoriatic Arthritis Product Overview

myPlan Renal Cancer

myPlan Renal Cancer Product Overview

myRisk Schizophrenia

myRisk Schizophrenia Product Overview

Prognostic Test-Bladder Cancer

Prognostic Test-Bladder Cancer Product Overview

SanoPredict

SanoPredict Product Overview

Tumor BRACAnalysis CDx-Veliparib

Tumor BRACAnalysis CDx-Veliparib Product Overview

VeriPsych Test-Bipolar Disorder

VeriPsych Test-Bipolar Disorder Product Overview

Myriad Genetics Inc-Key Competitors

Myriad Genetics Inc-Key Employees

Myriad Genetics Inc-Key Employee Biographies

Myriad Genetics Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Myriad Genetics Inc, Recent Developments

Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members

Sep 17, 2019: Myriad to initiate UK study of Prolaris test in prostate cancer

Aug 22, 2019: Myriad applauds the U.S. preventive services task force recommendation on BRCA-Related Cancer Prevention

Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results

Aug 07, 2019: Myriad will seek FDA approval of BRACAnalysis CDx as a companion diagnostic for Lynparza (Olaparib) in men with metastatic castrate-resistant prostate cancer

Jul 18, 2019: Myriad Genetics resolves Medicare Billing complaint for USD 9.1M

Jun 27, 2019: Prolaris Test accurately predicts risk of metastasis in men diagnosed with localized prostate cancer

Jun 25, 2019: Myriad announces publication of first comprehensive economic study demonstrating cost effectiveness of EndoPredict for Breast Cancer

Jun 19, 2019: Myriad Genetics receives second insurance reimbursement decision for its BRACAnalysis Diagnostic System in Japan

Jun 03, 2019: Myriad Genetics announces new results from two large studies of Its myRisk Hereditary Cancer Test at American Society of Clinical Oncology

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Myriad Genetics Inc Pipeline Products by Equipment Type

Myriad Genetics Inc Pipeline Products by Development Stage

Myriad Genetics Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Myriad Genetics Inc Pipeline Products and Ongoing Clinical Trials Overview

Myriad Genetics Inc Pipeline Products by Equipment Type

Myriad Genetics Inc Pipeline Products by Indication

Myriad Genetics Inc Ongoing Clinical Trials by Trial Status

Myriad Genetics Inc, Key Facts

Myriad Genetics Inc, Major Products and Services

Myriad Genetics Inc Number of Pipeline Products by Development Stage

Myriad Genetics Inc Pipeline Products Summary by Development Stage

Myriad Genetics Inc Ongoing Clinical Trials by Trial Status

Myriad Genetics Inc Ongoing Clinical Trials Summary

BRACAnalysis CDx-Metastatic Castrate-Resistant Prostate Cancer-Product Status

BRACAnalysis CDx-Metastatic Castrate-Resistant Prostate Cancer-Product Description

ChemoPredict Test-Product Status

ChemoPredict Test-Product Description

Diagnostic Assay-Lung Cancer-Product Status

Diagnostic Assay-Lung Cancer-Product Description

Diagnostic Assay-HER2+/TNBC-Breast Cancer-Product Status

Diagnostic Assay-HER2+/TNBC-Breast Cancer-Product Description

Diagnostic Assay-Juvenile Idiopathic Rheumatoid Arthritis-Product Status

Diagnostic Assay-Juvenile Idiopathic Rheumatoid Arthritis-Product Description

Diagnostic Assay-Melanoma-Product Status

Diagnostic Assay-Melanoma-Product Description

Diagnostic Assay-Prostate Cancer-Product Status

Diagnostic Assay-Prostate Cancer-Product Description

Diagnostic Test-Alzheimer's Disease-Product Status

Diagnostic Test-Alzheimer's Disease-Product Description

Diagnostic Test-Colon Cancer-Product Status

Diagnostic Test-Colon Cancer-Product Description

Diagnostic Test-Kidney Damage-Product Status

Diagnostic Test-Kidney Damage-Product Description

Genetic Risk Score Test-Product Status

Genetic Risk Score Test-Product Description

Genetic Risk Score Test-Clinical Trial to Examine Use of Predictive Genetic Tests for Cancer Risks Assessment

HRD Companion Diagnostic Test-Breast Cancer-Product Status

HRD Companion Diagnostic Test-Breast Cancer-Product Description

Kidney Transplant Rejection Test-Product Status

Kidney Transplant Rejection Test-Product Description

Multi-Biomarker Test-Ankylosing Spondylitis-Product Status

Multi-Biomarker Test-Ankylosing Spondylitis-Product Description

Multi-Biomarker Test-Autoimmune Diseases-Product Status

Multi-Biomarker Test-Autoimmune Diseases-Product Description

Multi-Biomarker Test-Inflammatory Diseases-Product Status

Multi-Biomarker Test-Inflammatory Diseases-Product Description

Multi-Biomarker Test-Psoriatic Arthritis-Product Status

Multi-Biomarker Test-Psoriatic Arthritis-Product Description

Multi-Biomarker Test-Systemic Lupus Erythematosus-Product Status

Multi-Biomarker Test-Systemic Lupus Erythematosus-Product Description

myChoice Diabetes-Product Status

myChoice Diabetes-Product Description

myChoice HRD (PARP)-Talazoparib-Product Status

myChoice HRD (PARP)-Talazoparib-Product Description

myChoice HRD CDx Test-Zejula-Product Status

myChoice HRD CDx Test-Zejula-Product Description

myChoice HRD CDx Test-Zejula-A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-line Platinum-based Chemotherapy

myChoice HRD CDx Test-Zejula-A Phase II, Open-label, Single-arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients with Advanced, Relapsed, High-grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

myChoice HRD CDx Test-Zejula-Phase I of Bevacizumab-niraparib Combination. AVANOVA2 -A 3-arm, Phase II Randomized Study of Niraparib &/or Niraparib-bevacizumab Combination Against Bevacizumab Alone in HRD Platinum-sensitive Epithelial Ovarian Cancer: AVANOVA1

myPath BiPolar-Product Status

myPath BiPolar-Product Description

myPath Endometriosis-Product Status

myPath Endometriosis-Product Description

myPath Pancreatic Cancer-Product Status

myPath Pancreatic Cancer-Product Description

myPath Prostate Cancer-Product Status

myPath Prostate Cancer-Product Description

myPath Psoriatic Arthritis-Product Status

myPath Psoriatic Arthritis-Product Description

myPlan Renal Cancer-Product Status

myPlan Renal Cancer-Product Description

myRisk Schizophrenia-Product Status

myRisk Schizophrenia-Product Description

Prognostic Test-Bladder Cancer-Product Status

Prognostic Test-Bladder Cancer-Product Description

SanoPredict-Product Status

SanoPredict-Product Description

Tumor BRACAnalysis CDx-Veliparib-Product Status

Tumor BRACAnalysis CDx-Veliparib-Product Description

VeriPsych Test-Bipolar Disorder-Product Status

VeriPsych Test-Bipolar Disorder-Product Description

Myriad Genetics Inc, Key Employees

Myriad Genetics Inc, Key Employee Biographies

Myriad Genetics Inc, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Myriad Genetics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Abbott Laboratories

Amgen Inc

Affymetrix, Inc.

Exact Sciences Corp

Siemens Healthineers AG

Hologic Inc

Nanosphere Inc

Company Profile

Company Profile Title

Summary

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company's product portfolio includes molecular diagnostic testing products that analyze genes, their expression levels and corresponding proteins to assess a person's risk for developing disease later in life; accurately diagnose disease; and determine a patient's likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Myriad Genetics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Myriad Genetics Inc Company Overview

Myriad Genetics Inc Company Snapshot

Myriad Genetics Inc Pipeline Products and Ongoing Clinical Trials Overview

Myriad Genetics Inc-Pipeline Analysis Overview

Business Description

Myriad Genetics Inc-Key Facts

Myriad Genetics Inc-Major Products and Services

Myriad Genetics Inc Pipeline Products by Development Stage

Myriad Genetics Inc Ongoing Clinical Trials by Trial Status

Myriad Genetics Inc Pipeline Products Overview

BRACAnalysis CDx-Metastatic Castrate-Resistant Prostate Cancer

BRACAnalysis CDx-Metastatic Castrate-Resistant Prostate Cancer Product Overview

ChemoPredict Test

ChemoPredict Test Product Overview

Diagnostic Assay-Lung Cancer

Diagnostic Assay-Lung Cancer Product Overview

Diagnostic Assay-HER2+/TNBC-Breast Cancer

Diagnostic Assay-HER2+/TNBC-Breast Cancer Product Overview

Diagnostic Assay-Juvenile Idiopathic Rheumatoid Arthritis

Diagnostic Assay-Juvenile Idiopathic Rheumatoid Arthritis Product Overview

Diagnostic Assay-Melanoma

Diagnostic Assay-Melanoma Product Overview

Diagnostic Assay-Prostate Cancer

Diagnostic Assay-Prostate Cancer Product Overview

Diagnostic Test-Alzheimer's Disease

Diagnostic Test-Alzheimer's Disease Product Overview

Diagnostic Test-Colon Cancer

Diagnostic Test-Colon Cancer Product Overview

Diagnostic Test-Kidney Damage

Diagnostic Test-Kidney Damage Product Overview

Genetic Risk Score Test

Genetic Risk Score Test Product Overview

Genetic Risk Score Test Clinical Trial

HRD Companion Diagnostic Test-Breast Cancer

HRD Companion Diagnostic Test-Breast Cancer Product Overview

Kidney Transplant Rejection Test

Kidney Transplant Rejection Test Product Overview

Multi-Biomarker Test-Ankylosing Spondylitis

Multi-Biomarker Test-Ankylosing Spondylitis Product Overview

Multi-Biomarker Test-Autoimmune Diseases

Multi-Biomarker Test-Autoimmune Diseases Product Overview

Multi-Biomarker Test-Inflammatory Diseases

Multi-Biomarker Test-Inflammatory Diseases Product Overview

Multi-Biomarker Test-Psoriatic Arthritis

Multi-Biomarker Test-Psoriatic Arthritis Product Overview

Multi-Biomarker Test-Systemic Lupus Erythematosus

Multi-Biomarker Test-Systemic Lupus Erythematosus Product Overview

myChoice Diabetes

myChoice Diabetes Product Overview

myChoice HRD (PARP)-Talazoparib

myChoice HRD (PARP)-Talazoparib Product Overview

myChoice HRD CDx Test-Zejula

myChoice HRD CDx Test-Zejula Product Overview

myChoice HRD CDx Test-Zejula Clinical Trial

myPath BiPolar

myPath BiPolar Product Overview

myPath Endometriosis

myPath Endometriosis Product Overview

myPath Pancreatic Cancer

myPath Pancreatic Cancer Product Overview

myPath Prostate Cancer

myPath Prostate Cancer Product Overview

myPath Psoriatic Arthritis

myPath Psoriatic Arthritis Product Overview

myPlan Renal Cancer

myPlan Renal Cancer Product Overview

myRisk Schizophrenia

myRisk Schizophrenia Product Overview

Prognostic Test-Bladder Cancer

Prognostic Test-Bladder Cancer Product Overview

SanoPredict

SanoPredict Product Overview

Tumor BRACAnalysis CDx-Veliparib

Tumor BRACAnalysis CDx-Veliparib Product Overview

VeriPsych Test-Bipolar Disorder

VeriPsych Test-Bipolar Disorder Product Overview

Myriad Genetics Inc-Key Competitors

Myriad Genetics Inc-Key Employees

Myriad Genetics Inc-Key Employee Biographies

Myriad Genetics Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Myriad Genetics Inc, Recent Developments

Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members

Sep 17, 2019: Myriad to initiate UK study of Prolaris test in prostate cancer

Aug 22, 2019: Myriad applauds the U.S. preventive services task force recommendation on BRCA-Related Cancer Prevention

Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results

Aug 07, 2019: Myriad will seek FDA approval of BRACAnalysis CDx as a companion diagnostic for Lynparza (Olaparib) in men with metastatic castrate-resistant prostate cancer

Jul 18, 2019: Myriad Genetics resolves Medicare Billing complaint for USD 9.1M

Jun 27, 2019: Prolaris Test accurately predicts risk of metastasis in men diagnosed with localized prostate cancer

Jun 25, 2019: Myriad announces publication of first comprehensive economic study demonstrating cost effectiveness of EndoPredict for Breast Cancer

Jun 19, 2019: Myriad Genetics receives second insurance reimbursement decision for its BRACAnalysis Diagnostic System in Japan

Jun 03, 2019: Myriad Genetics announces new results from two large studies of Its myRisk Hereditary Cancer Test at American Society of Clinical Oncology

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Myriad Genetics Inc Pipeline Products by Equipment Type

Myriad Genetics Inc Pipeline Products by Development Stage

Myriad Genetics Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Myriad Genetics Inc Pipeline Products and Ongoing Clinical Trials Overview

Myriad Genetics Inc Pipeline Products by Equipment Type

Myriad Genetics Inc Pipeline Products by Indication

Myriad Genetics Inc Ongoing Clinical Trials by Trial Status

Myriad Genetics Inc, Key Facts

Myriad Genetics Inc, Major Products and Services

Myriad Genetics Inc Number of Pipeline Products by Development Stage

Myriad Genetics Inc Pipeline Products Summary by Development Stage

Myriad Genetics Inc Ongoing Clinical Trials by Trial Status

Myriad Genetics Inc Ongoing Clinical Trials Summary

BRACAnalysis CDx-Metastatic Castrate-Resistant Prostate Cancer-Product Status

BRACAnalysis CDx-Metastatic Castrate-Resistant Prostate Cancer-Product Description

ChemoPredict Test-Product Status

ChemoPredict Test-Product Description

Diagnostic Assay-Lung Cancer-Product Status

Diagnostic Assay-Lung Cancer-Product Description

Diagnostic Assay-HER2+/TNBC-Breast Cancer-Product Status

Diagnostic Assay-HER2+/TNBC-Breast Cancer-Product Description

Diagnostic Assay-Juvenile Idiopathic Rheumatoid Arthritis-Product Status

Diagnostic Assay-Juvenile Idiopathic Rheumatoid Arthritis-Product Description

Diagnostic Assay-Melanoma-Product Status

Diagnostic Assay-Melanoma-Product Description

Diagnostic Assay-Prostate Cancer-Product Status

Diagnostic Assay-Prostate Cancer-Product Description

Diagnostic Test-Alzheimer's Disease-Product Status

Diagnostic Test-Alzheimer's Disease-Product Description

Diagnostic Test-Colon Cancer-Product Status

Diagnostic Test-Colon Cancer-Product Description

Diagnostic Test-Kidney Damage-Product Status

Diagnostic Test-Kidney Damage-Product Description

Genetic Risk Score Test-Product Status

Genetic Risk Score Test-Product Description

Genetic Risk Score Test-Clinical Trial to Examine Use of Predictive Genetic Tests for Cancer Risks Assessment

HRD Companion Diagnostic Test-Breast Cancer-Product Status

HRD Companion Diagnostic Test-Breast Cancer-Product Description

Kidney Transplant Rejection Test-Product Status

Kidney Transplant Rejection Test-Product Description

Multi-Biomarker Test-Ankylosing Spondylitis-Product Status

Multi-Biomarker Test-Ankylosing Spondylitis-Product Description

Multi-Biomarker Test-Autoimmune Diseases-Product Status

Multi-Biomarker Test-Autoimmune Diseases-Product Description

Multi-Biomarker Test-Inflammatory Diseases-Product Status

Multi-Biomarker Test-Inflammatory Diseases-Product Description

Multi-Biomarker Test-Psoriatic Arthritis-Product Status

Multi-Biomarker Test-Psoriatic Arthritis-Product Description

Multi-Biomarker Test-Systemic Lupus Erythematosus-Product Status

Multi-Biomarker Test-Systemic Lupus Erythematosus-Product Description

myChoice Diabetes-Product Status

myChoice Diabetes-Product Description

myChoice HRD (PARP)-Talazoparib-Product Status

myChoice HRD (PARP)-Talazoparib-Product Description

myChoice HRD CDx Test-Zejula-Product Status

myChoice HRD CDx Test-Zejula-Product Description

myChoice HRD CDx Test-Zejula-A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-line Platinum-based Chemotherapy

myChoice HRD CDx Test-Zejula-A Phase II, Open-label, Single-arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients with Advanced, Relapsed, High-grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

myChoice HRD CDx Test-Zejula-Phase I of Bevacizumab-niraparib Combination. AVANOVA2 -A 3-arm, Phase II Randomized Study of Niraparib &/or Niraparib-bevacizumab Combination Against Bevacizumab Alone in HRD Platinum-sensitive Epithelial Ovarian Cancer: AVANOVA1

myPath BiPolar-Product Status

myPath BiPolar-Product Description

myPath Endometriosis-Product Status

myPath Endometriosis-Product Description

myPath Pancreatic Cancer-Product Status

myPath Pancreatic Cancer-Product Description

myPath Prostate Cancer-Product Status

myPath Prostate Cancer-Product Description

myPath Psoriatic Arthritis-Product Status

myPath Psoriatic Arthritis-Product Description

myPlan Renal Cancer-Product Status

myPlan Renal Cancer-Product Description

myRisk Schizophrenia-Product Status

myRisk Schizophrenia-Product Description

Prognostic Test-Bladder Cancer-Product Status

Prognostic Test-Bladder Cancer-Product Description

SanoPredict-Product Status

SanoPredict-Product Description

Tumor BRACAnalysis CDx-Veliparib-Product Status

Tumor BRACAnalysis CDx-Veliparib-Product Description

VeriPsych Test-Bipolar Disorder-Product Status

VeriPsych Test-Bipolar Disorder-Product Description

Myriad Genetics Inc, Key Employees

Myriad Genetics Inc, Key Employee Biographies

Myriad Genetics Inc, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Myriad Genetics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Abbott Laboratories

Amgen Inc

Affymetrix, Inc.

Exact Sciences Corp

Siemens Healthineers AG

Hologic Inc

Nanosphere Inc